Patients who fasted during chemotherapy for ovarian cancer had significantly longer progression-free survival (PFS) compared ...
Resources for observational comparative research have expanded enormously in recent years to include very large sources of ...
China: Researchers have found in a randomized clinical trial that intra-arterial alteplase given after successful ...
An official from the US Food and Drug Administration (FDA) on Monday presented three case studies demonstrating how sponsors effectively utilized real-world evidence (RWE) and real-world data (RWD) to ...
Mehul V. Raval, MD, MS, discusses newly published findings from the ENRICH-US trial which evaluated the impact of a pediatric ...
Israeli Ministry of Health approved the initiation of Silexion's Phase 2/3 clinical trial of SIL204 in locally advanced ...
Benralizumab gained approval for adult and pediatric hypereosinophilic syndrome with a 65% flare-risk reduction, underscoring lifecycle strategies that impose distinct dosing, formulation, and ...
A BC-led clinical research team is behind a study that could help improve care for critically ill patients in intensive care ...
A B.C.-led clinical research team is behind a study that could help improve care for critically ill patients in intensive ...
MarketBeat on MSN
Adagene Spotlights ADG126 Strategy as Masked CTLA-4 Trial Advances in Colorectal Cancer
Adagene (NASDAQ:ADAG) Chief Strategy Officer Mickael Chane-Du outlined the company's clinical strategy for its lead antibody program, ADG126, during a discussion with Stifel senior biotech analyst ...
In patients with very high risk, high grade T1 with CIS NMIBC, the possible value of adding immune checkpoint blockade to BCG has not been defined.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results